Concurrently, NSCLC cell lines with KEAP1/NFE2L2 mutations present increased expression of some NFE2L2 target genes, such as HMOX1, GCLCM, TXN, GCLC, NQO1 or GSR [98]. This evidence concerns the gene KEAP1 and non-small cell lung carcinoma.